Beneficial effects of flavonoids on cardiovascular diseases by influencing NLRP3 inflammasome

• Published in: Inflammopharmacology Vol. 31; no. 4; pp. 1715 - 1729
• Main Authors: Fang, Hai-yan, Zhao, Xiao-ni, Zhang, Meng, Ma, Yao-yao, Huang, Jin-ling, Zhou, Peng
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.08.2023
• Subjects: Allergology; Biomedical and Life Sciences; Biomedicine; Cardiovascular Diseases - drug therapy; Dermatology; Flavonoids - pharmacology; Gastroenterology; Humans; Immunology; Inflammasomes - metabolism; Molecular Docking Simulation; NLR Family, Pyrin Domain-Containing 3 Protein - metabolism; Pharmacology/Toxicology; Review; Rheumatology; Flavonoids; Cardiovascular diseases; NLRP3 inflammasome; Molecular docking
• ISSN: 0925-4692; 1568-5608; 1568-5608
• DOI: 10.1007/s10787-023-01249-2

Cardiovascular diseases (CVDs) are a leading cause of global mortality and have a high incidence rate worldwide. The function of inflammasomes in CVDs has received a lot of attention recently, and the nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) inflammasome may be a new target for the prevention and treatment of CVDs. Flavonoids, which are found in food and plant extracts, inhibited inflammation in CVDs by regulating the NLRP3 inflammasome. CB-Dock was used to investigate whether 34 flavonoids from natural products acted on NLRP3 inflammasome. In brief, the PDB format of NLRP3 was selected as a protein file, and 34 flavonoids in SDF format were selected as the ligand file, and then input to CB-Dock for molecular docking. The docking results showed that epigallocatechin-3-gallate (EGCG), amentoflavone, baicalin, scutellarin, vitexin, silibinin, and puerarin had good binding affinities to NLRP3, which could be used as NLRP3 inhibitors, and aid in the discovery of lead compounds for the design and development of CVDs.